What are the components of ENTADFI?
ENTADFI is a combination of finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor.1
How is ENTADFI taken?
ENTADFI is taken once daily without food—approximately the same time every day for up to 26 weeks.1
What is the dose form and strength of ENTADFI?
ENTADFI includes finasteride 5 mg and tadalafil 5 mg, in a size-3 capsule with an opaque white cap and body with a black two-lined bar printed on
the cap and body.1
How was the study that compared ENTADFI therapy to finasteride designed?
The study was an international, randomized, double-blind, parallel-design trial that measured the efficacy and safety of tadalafil 5 mg once daily
combined with finasteride 5 mg for 26 weeks compared to placebo combined with finasteride 5 mg in men with BPH-LUTS and prostatic enlargement.1
What makes ENTADFI unique?
Faster and better relief of BPH with fewer sexual side effects1,2
References: 1. ENTADFI. Prescribing information. Veru Inc.; 2022. 2. Casabé A, Roehrborn CG, Da Pozzo LF, et al. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia. J Urol. 2014;191(3):727-733. doi:10.1016/j.juro.2013.09.059 3. D’Silva KA, Dahm P, Wong CL. Does this man with lower urinary tract symptoms have bladder outlet obstruction?: The Rational Clinical Examination: a systematic review. JAMA. 2014;312(5):535-542. doi:10.1001/jama.2014.5555